|
A more recent version of this article appeared on September 23, 2005
Papers In Press, published online ahead of print August 1, 2005
J. Biol. Chem, 10.1074/jbc.M506758200
Submitted on June 21, 2005
Revised on July 25, 2005
Accepted on August 1, 2005
Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor- and is involved in the regulation of receptor activity
Senad Medunjanin, Alexander Hermani, Barbara De Servi, Jean Grisouard, Gabriele Rincke, and Doris Mayer
Department of Hormones and Signal Transduction Group, German Cancer Research Center, Heidelberg 69120
Corresponding Author: d.mayer{at}dkfz.de
Like other steroid hormone receptors, estrogen receptor-a (ERa) is a substrate for protein kinases, and phosphorylation has profound effects on the function and activity of this receptor. A number of different kinases have been implicated in ERa regulation. In this report we show by mutational analysis and in vitro kinase assays that ERa is a substrate for glycogen synthase kinase-3 (GSK-3) in vitro and is phosphorylated on two sites, the Ser102,104,106 motif and Ser118, both located in the N-terminal transcription activation function (AF-1) domain. GSK-3 forms a complex with ERa in vivo as demonstrated by co-immunoprecipitation from cell lysates. The GSK-3 inhibitor lithium chloride was used to determine the role of GSK-3 in phosphorylation of Ser102,104,106 and Ser118 in vivo and to explore the role of these serines in the regulation of ERa function. Treatment of cells with lithium chloride resulted in dephosphorylation of Ser104,106 and Ser118 which suggests these serine residues as targets for GSK-3 in vivo. Our results further suggest that ERa phosphorylation by GSK-3 stabilizes ERa under resting conditions and modulates ERa transcriptional activity upon ligand binding. Inhibition and constitutive activation of GSK-3 both resulted in inhibition of ERa transcriptional activity indicating a function of active as well as inactive GSK-3 in ERa regulation. These findings uncover a novel mechanism for the regulation of ERa-mediated estrogen signaling controlled by a dual action of GSK-3.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. S Thomas, N. Sarwar, F. Phoenix, R C. Coombes, and S. Ali
Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-{alpha} activity
J. Mol. Endocrinol.,
April 1, 2008;
40(4):
173 - 184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. H. Ing, D. A. Massuto, and L. A. Jaeger
Estradiol Up-regulates AUF1p45 Binding to Stabilizing Regions within the 3'-Untranslated Region of Estrogen Receptor {alpha} mRNA
J. Biol. Chem.,
January 18, 2008;
283(3):
1764 - 1772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. De los Santos, O. Martinez-Iglesias, and A. Aranda
Anti-estrogenic actions of histone deacetylase inhibitors in MCF-7 breast cancer cells
Endocr. Relat. Cancer,
December 1, 2007;
14(4):
1021 - 1028.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Grisouard, S. Medunjanin, A. Hermani, A. Shukla, and D. Mayer
Glycogen Synthase Kinase-3 Protects Estrogen Receptor {alpha} from Proteasomal Degradation and Is Required for Full Transcriptional Activity of the Receptor
Mol. Endocrinol.,
October 1, 2007;
21(10):
2427 - 2439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Murphy and C. Steenbergen
Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury
Cardiovasc Res,
August 1, 2007;
75(3):
478 - 486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Vasudevan and D. W. Pfaff
Membrane-Initiated Actions of Estrogens in Neuroendocrinology: Emerging Principles
Endocr. Rev.,
February 1, 2007;
28(1):
1 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. S. Likhite, F. Stossi, K. Kim, B. S. Katzenellenbogen, and J. A. Katzenellenbogen
Kinase-Specific Phosphorylation of the Estrogen Receptor Changes Receptor Interactions with Ligand, Deoxyribonucleic Acid, and Coregulators Associated with Alterations in Estrogen and Tamoxifen Activity
Mol. Endocrinol.,
December 1, 2006;
20(12):
3120 - 3132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Acconcia, B. Manavathi, J. Mascarenhas, A. H. Talukder, G. Mills, and R. Kumar
An Inherent Role of Integrin-Linked Kinase-Estrogen Receptor {alpha} Interaction in Cell Migration.
Cancer Res.,
November 15, 2006;
66(22):
11030 - 11038.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Sarwar, J-S Kim, J Jiang, D Peston, H D Sinnett, P Madden, J M Gee, R I Nicholson, A E Lykkesfeldt, S Shousha, et al.
Phosphorylation of ER{alpha} at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ER{alpha} phosphorylation in breast cancer progression.
Endocr. Relat. Cancer,
September 1, 2006;
13(3):
851 - 861.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mendez and L. M. Garcia-Segura
Phosphatidylinositol 3-Kinase and Glycogen Synthase Kinase 3 Regulate Estrogen Receptor-Mediated Transcription in Neuronal Cells
Endocrinology,
June 1, 2006;
147(6):
3027 - 3039.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|